Ablynx: Another positive development for Ablynx as BI enters phase I in Alzheimer’s disease

CORPORATE, Fair Value EUR11 (+49%)

News published on October Tuesday 29, 2013
Share on

The Essentials

Everything you need to know about investment banking dedicated to growth
Stay Informed
Get our news
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities